A cross-sectional study of the microeconomic impact of cardiovascular disease hospitalization in four low- and middle-income countries.

PubWeight™: 2.23‹?› | Rank: Top 2%

🔗 View Article (PMC 3114849)

Published in PLoS One on June 14, 2011

Authors

Mark D Huffman1, Krishna D Rao, Andres Pichon-Riviere, Dong Zhao, S Harikrishnan, Kaushik Ramaiya, V S Ajay, Shifalika Goenka, Juan I Calcagno, Joaquín E Caporale, Shaoli Niu, Yan Li, Jing Liu, K R Thankappan, Meena Daivadanam, Jan van Esch, Adrianna Murphy, Andrew E Moran, Thomas A Gaziano, Marc Suhrcke, K Srinath Reddy, Stephen Leeder, Dorairaj Prabhakaran

Author Affiliations

1: Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America.

Articles citing this

Presentation, management, and outcomes of 25 748 acute coronary syndrome admissions in Kerala, India: results from the Kerala ACS Registry. Eur Heart J (2012) 2.90

Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76

Temporal trends in ischemic heart disease mortality in 21 world regions, 1980 to 2010: the Global Burden of Disease 2010 study. Circulation (2014) 2.66

Commentary: Poverty and cardiovascular disease in India: do we need more evidence for action? Int J Epidemiol (2013) 1.80

Resource Effective Strategies to Prevent and Treat Cardiovascular Disease. Circulation (2016) 1.40

Lack of focus on cardiovascular disease in sub-Saharan Africa. Cardiovasc Diagn Ther (2012) 1.28

Examining inequities in incidence of catastrophic health expenditures on different healthcare services and health facilities in Nigeria. PLoS One (2012) 1.18

The economic burden of chronic disease care faced by households in Ukraine: a cross-sectional matching study of angina patients. Int J Equity Health (2013) 1.12

Optimal in-hospital and discharge medical therapy in acute coronary syndromes in Kerala: results from the Kerala acute coronary syndrome registry. Circ Cardiovasc Qual Outcomes (2013) 1.09

Heart failure in South Asia. Curr Cardiol Rev (2013) 0.97

Pathways to catastrophic health expenditure for acute coronary syndrome in Kerala: 'Good health at low cost'? BMC Public Health (2012) 0.96

The prevalence and determinants of catastrophic health expenditures attributable to non-communicable diseases in low- and middle-income countries: a methodological commentary. Int J Equity Health (2014) 0.93

Global perspective on acute coronary syndrome: a burden on the young and poor. Circ Res (2014) 0.93

Age and sex pattern of cardiovascular mortality, hospitalisation and associated cost in India. PLoS One (2013) 0.91

The global impact of non-communicable diseases on households and impoverishment: a systematic review. Eur J Epidemiol (2014) 0.89

The perceived cancer-related financial hardship among patients and their families: a systematic review. Support Care Cancer (2014) 0.89

The Cost-Effectiveness of Low-Cost Essential Antihypertensive Medicines for Hypertension Control in China: A Modelling Study. PLoS Med (2015) 0.89

Cardiovascular disease and impoverishment averted due to a salt reduction policy in South Africa: an extended cost-effectiveness analysis. Health Policy Plan (2015) 0.89

Self-reported illness and household strategies for coping with health-care payments in Bangladesh. Bull World Health Organ (2013) 0.88

Out-of-pocket expenditure on chronic non-communicable diseases in sub-Saharan Africa: the case of rural Malawi. PLoS One (2015) 0.88

Design and methodology of a community-based cluster-randomized controlled trial for dietary behaviour change in rural Kerala. Glob Health Action (2013) 0.86

The economic burden of self-reported and undiagnosed cardiovascular diseases and diabetes on Indonesian households. PLoS One (2014) 0.85

Diabetes, HIV and other health determinants associated with absenteeism among formal sector workers in Namibia. BMC Public Health (2012) 0.83

Barriers to translating EU and US CVD guidelines into practice in China. Nat Rev Cardiol (2012) 0.80

Engaging the Entire Care Cascade in Western Kenya: A Model to Achieve the Cardiovascular Disease Secondary Prevention Roadmap Goals. Glob Heart (2015) 0.79

The need for better evidence to evaluate the health & economic benefits of India's Rashtriya Swasthya Bima Yojana. Indian J Med Res (2015) 0.79

Catastrophic health expenditure on acute coronary events in Asia: a prospective study. Bull World Health Organ (2016) 0.79

Estimation of the cost-effectiveness of apixaban versus vitamin K antagonists in the management of atrial fibrillation in Argentina. Health Econ Rev (2015) 0.78

The economic burden of angina on households in South Asia. BMC Public Health (2014) 0.77

Economic Burden of Hospitalization Due to Injuries in North India: A Cohort Study. Int J Environ Res Public Health (2016) 0.77

Assessment of demographics, treatment strategies, and evidence-based medicine use among diabetic and non-diabetic patients with acute coronary syndrome: A cohort study. J Pharmacol Pharmacother (2014) 0.76

Trends in cardiac biomarker testing in China for patients with acute myocardial infarction, 2001 to 2011: China PEACE-retrospective AMI study. PLoS One (2015) 0.76

Projected Impact of Salt Restriction on Prevention of Cardiovascular Disease in China: A Modeling Study. PLoS One (2016) 0.76

Inequalities in financial risk protection in Bangladesh: an assessment of universal health coverage. Int J Equity Health (2017) 0.75

The economic burden of chronic non-communicable diseases in rural Malawi: an observational study. BMC Health Serv Res (2016) 0.75

Cardiovascular disease research and the development agenda in low- and middle-income countries. Glob Heart (2015) 0.75

Pre-hospital acute coronary syndrome care in Kerala, India: A qualitative analysis. Indian Heart J (2016) 0.75

Pre-hospital policies for the care of patients with acute coronary syndromes in India: A policy document analysis. Indian Heart J (2016) 0.75

Setting priorities to address cardiovascular diseases through universal health coverage in low- and middle-income countries. Heart Asia (2017) 0.75

Good news for Kerala. Indian Heart J (2016) 0.75

Cardiovascular disease prevention in South Asia: gathering the evidence. Glob Heart (2013) 0.75

Acute coronary syndrome quality improvement in Kerala (ACS QUIK): Rationale and design for a cluster-randomized stepped-wedge trial. Am Heart J (2016) 0.75

The Financial Burden of Non-Communicable Chronic Diseases in Rural Nigeria: Wealth and Gender Heterogeneity in Health Care Utilization and Health Expenditures. PLoS One (2016) 0.75

Cost-effectiveness of milk powder fortified with potassium to decrease blood pressure and prevent cardiovascular events among the adult population in China: a Markov model. BMJ Open (2017) 0.75

Articles by these authors

A draft sequence of the rice genome (Oryza sativa L. ssp. indica). Science (2002) 42.78

Topological domains in mammalian genomes identified by analysis of chromatin interactions. Nature (2012) 18.23

Global health 2035: a world converging within a generation. Lancet (2013) 16.85

The Genome sequence of the SARS-associated coronavirus. Science (2003) 16.68

Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA (2003) 16.08

Priority actions for the non-communicable disease crisis. Lancet (2011) 15.18

The public health effect of economic crises and alternative policy responses in Europe: an empirical analysis. Lancet (2009) 15.10

Preventing chronic diseases: how many lives can we save? Lancet (2005) 14.77

Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25

Towards a common definition of global health. Lancet (2009) 12.36

Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases. Cancer Cell (2011) 11.44

Relation of serial changes in childhood body-mass index to impaired glucose tolerance in young adulthood. N Engl J Med (2004) 11.09

Genome-wide association study of 107 phenotypes in Arabidopsis thaliana inbred lines. Nature (2010) 10.66

The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA (2013) 10.43

Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature (2007) 10.40

Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med (2011) 10.29

Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet (2014) 10.06

Comparative genome sequencing of Drosophila pseudoobscura: chromosomal, gene, and cis-element evolution. Genome Res (2005) 8.38

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2015) 7.99

Modelling schizophrenia using human induced pluripotent stem cells. Nature (2011) 7.41

Expansion of cancer care and control in countries of low and middle income: a call to action. Lancet (2010) 6.84

Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute. Circulation (2003) 6.47

A distinct lineage of influenza A virus from bats. Proc Natl Acad Sci U S A (2012) 6.27

Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet (2015) 6.13

Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ (2014) 5.88

Trends in survival after in-hospital cardiac arrest. N Engl J Med (2012) 5.67

Characterization of human metapneumoviruses isolated from patients in North America. J Infect Dis (2002) 5.64

Chronic diseases now a leading cause of death in rural India--mortality data from the Andhra Pradesh Rural Health Initiative. Int J Epidemiol (2006) 5.60

Effect of iodine intake on thyroid diseases in China. N Engl J Med (2006) 5.46

Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat Med (2003) 5.45

Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study. JAMA (2004) 5.34

Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data. Lancet (2008) 5.27

Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association. Circulation (2011) 5.26

Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet (2007) 5.21

A high-resolution map of the three-dimensional chromatin interactome in human cells. Nature (2013) 5.18

Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial. JAMA (2013) 4.82

The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: endorsed by the World Heart Federation. J Am Coll Cardiol (2013) 4.81

Effects of the 2008 recession on health: a first look at European data. Lancet (2011) 4.80

Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation. Science (2006) 4.71

Exogenous plant MIR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom regulation by microRNA. Cell Res (2011) 4.55

Prasugrel versus clopidogrel for acute coronary syndromes without revascularization. N Engl J Med (2012) 4.49

Off-pump or on-pump coronary-artery bypass grafting at 30 days. N Engl J Med (2012) 4.32

Human illness from avian influenza H7N3, British Columbia. Emerg Infect Dis (2004) 4.29

Effects of off-pump and on-pump coronary-artery bypass grafting at 1 year. N Engl J Med (2013) 4.27

Chronic diseases and injuries in India. Lancet (2011) 4.27

Burden of non-communicable diseases in South Asia. BMJ (2004) 4.19

Noncommunicable diseases. N Engl J Med (2013) 4.17

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial. Ann Surg Oncol (2011) 4.16

Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs. Lancet (2007) 4.15

New world bats harbor diverse influenza A viruses. PLoS Pathog (2013) 4.10

Risk factor profile for chronic non-communicable diseases: results of a community-based study in Kerala, India. Indian J Med Res (2010) 3.92

Evaluation of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina: results from the TERISA randomized clinical trial (Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina). J Am Coll Cardiol (2013) 3.90

Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin. Mol Cell (2005) 3.89

Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada. PLoS Med (2010) 3.85

Long-term outcomes in elderly survivors of in-hospital cardiac arrest. N Engl J Med (2013) 3.85

The complete genomes and proteomes of 27 Staphylococcus aureus bacteriophages. Proc Natl Acad Sci U S A (2005) 3.84

Epigenomic analysis of multilineage differentiation of human embryonic stem cells. Cell (2013) 3.81

Epidemiological transition of stroke in China: twenty-one-year observational study from the Sino-MONICA-Beijing Project. Stroke (2008) 3.81

Methods for establishing a surveillance system for cardiovascular diseases in Indian industrial populations. Bull World Health Organ (2006) 3.77

UN High-Level Meeting on Non-Communicable Diseases: addressing four questions. Lancet (2011) 3.68

Evidence-based intervention in physical activity: lessons from around the world. Lancet (2012) 3.64

Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung. Nat Biotechnol (2007) 3.54

Regulation of Notch1 and Dll4 by vascular endothelial growth factor in arterial endothelial cells: implications for modulating arteriogenesis and angiogenesis. Mol Cell Biol (2003) 3.51

Genetic variants and risk of lung cancer in never smokers: a genome-wide association study. Lancet Oncol (2010) 3.49

AMPylation of Rho GTPases by Vibrio VopS disrupts effector binding and downstream signaling. Science (2008) 3.44

Quantitative susceptibility map reconstruction from MR phase data using bayesian regularization: validation and application to brain imaging. Magn Reson Med (2010) 3.43

Human resources for health in India. Lancet (2011) 3.42

Ambulatory arterial stiffness index as a predictor of cardiovascular mortality in the Dublin Outcome Study. Hypertension (2006) 3.42

Human Bocavirus infection, Canada. Emerg Infect Dis (2006) 3.30

Pre-existing AAV capsid-specific CD8+ T cells are unable to eliminate AAV-transduced hepatocytes. Mol Ther (2007) 3.26

Scaling up interventions for chronic disease prevention: the evidence. Lancet (2007) 3.24

Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy. Nature (2004) 3.24

Growing epidemic of coronary heart disease in low- and middle-income countries. Curr Probl Cardiol (2010) 3.23

The effect of rural-to-urban migration on obesity and diabetes in India: a cross-sectional study. PLoS Med (2010) 3.16

A Pseudomonas syringae effector inactivates MAPKs to suppress PAMP-induced immunity in plants. Cell Host Microbe (2007) 3.15

The scale of population structure in Arabidopsis thaliana. PLoS Genet (2010) 3.12

PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity. J Cell Biol (2014) 3.12

Triple reassortant H3N2 influenza A viruses, Canada, 2005. Emerg Infect Dis (2006) 3.05

Label-free, normalized quantification of complex mass spectrometry data for proteomic analysis. Nat Biotechnol (2009) 3.01

Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26. Nature (2013) 3.00

Resolving the distinct stages in erythroid differentiation based on dynamic changes in membrane protein expression during erythropoiesis. Proc Natl Acad Sci U S A (2009) 3.00

Judging nudging: can nudging improve population health? BMJ (2011) 2.99

Identification of a novel astrovirus (astrovirus VA1) associated with an outbreak of acute gastroenteritis. J Virol (2009) 2.96

Smoking during pregnancy and newborn neurobehavior. Pediatrics (2003) 2.93

Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis. Lancet Oncol (2012) 2.91

Novel avian influenza H7N3 strain outbreak, British Columbia. Emerg Infect Dis (2004) 2.90

Presentation, management, and outcomes of 25 748 acute coronary syndrome admissions in Kerala, India: results from the Kerala ACS Registry. Eur Heart J (2012) 2.90

Masked hypertension in diabetes mellitus: treatment implications for clinical practice. Hypertension (2013) 2.89

Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association. J Am Coll Cardiol (2011) 2.89

The integrated response of the human cerebro-cerebellar and limbic systems to acupuncture stimulation at ST 36 as evidenced by fMRI. Neuroimage (2005) 2.86